Sofi Sennefelt Nyman
Doktorand vid Institutionen för kirurgiska vetenskaper; Radiologi
- Mobiltelefon:
- 073-827 20 17
- E-post:
- sofi.nyman@uu.se
- Besöksadress:
- Akademiska sjukhuset, ingång 70, 1tr
- Postadress:
- Akademiska sjukhuset, ingång 70, 1tr
751 85 UPPSALA
Publikationer
Senaste publikationer
Ingår i Molecular Metabolism, 2024
- DOI för Inhibiting the endoplasmic reticulum stress response enhances the effect of doxorubicin by altering the lipid metabolism of liver cancer cells
- Ladda ner fulltext (pdf) av Inhibiting the endoplasmic reticulum stress response enhances the effect of doxorubicin by altering the lipid metabolism of liver cancer cells
Ingår i Acta Radiologica, s. 1323-1331, 2022
- DOI för Peritumoral portal enhancement during transarterial chemoembolization: a potential prognostic factor for patients with hepatocellular carcinoma.
- Ladda ner fulltext (pdf) av Peritumoral portal enhancement during transarterial chemoembolization: a potential prognostic factor for patients with hepatocellular carcinoma.
Ingår i BMJ Open, 2022
- DOI för Study protocol for locoregional precision treatment of hepatocellular carcinoma with transarterial chemoembolisation (TACTida), a clinical study: idarubicin dose selection, tissue response and survival
- Ladda ner fulltext (pdf) av Study protocol for locoregional precision treatment of hepatocellular carcinoma with transarterial chemoembolisation (TACTida), a clinical study: idarubicin dose selection, tissue response and survival
Alla publikationer
Artiklar i tidskrift
Ingår i Molecular Metabolism, 2024
- DOI för Inhibiting the endoplasmic reticulum stress response enhances the effect of doxorubicin by altering the lipid metabolism of liver cancer cells
- Ladda ner fulltext (pdf) av Inhibiting the endoplasmic reticulum stress response enhances the effect of doxorubicin by altering the lipid metabolism of liver cancer cells
Ingår i Acta Radiologica, s. 1323-1331, 2022
- DOI för Peritumoral portal enhancement during transarterial chemoembolization: a potential prognostic factor for patients with hepatocellular carcinoma.
- Ladda ner fulltext (pdf) av Peritumoral portal enhancement during transarterial chemoembolization: a potential prognostic factor for patients with hepatocellular carcinoma.
Ingår i BMJ Open, 2022
- DOI för Study protocol for locoregional precision treatment of hepatocellular carcinoma with transarterial chemoembolisation (TACTida), a clinical study: idarubicin dose selection, tissue response and survival
- Ladda ner fulltext (pdf) av Study protocol for locoregional precision treatment of hepatocellular carcinoma with transarterial chemoembolisation (TACTida), a clinical study: idarubicin dose selection, tissue response and survival